Extended observations on MS patients treated with IM interferon-β1a (Avonex™): implications for modern MS trials and therapeutics
Authors:
- Lawrence JacobsLJLawrence Jacobs
- Richard RudickRRRichard Rudick
- Jack SimonJSJack Simon
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 107 (2) , 167-173
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- The interferons: Biological effects, mechanisms of action, and use in multiple sclerosisAnnals of Neurology, 1995
- The immunology of multiple sclerosisCurrent Opinion in Neurology, 1994
- Interferon-β specifically inhibits interferon-γ-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell lineJournal of Neuroimmunology, 1991
- Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytesJournal of Neuroimmunology, 1989
- Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens.Journal of Experimental Medicine, 1986
- Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in ratsInflammation Research, 1985
- Inducible expression of H–2 and Ia antigens on brain cellsNature, 1984
- Inhibition of Passive Localized Experimental Allergic Encephalomyelitis by InterferonInternational Archives of Allergy and Immunology, 1983
- Suppression of Experimental Allergic Encephalomyelitis by InterferonImmunological Communications, 1982